Restylane Eyelight Lidocaine

Restylane Eyelight Lidocaine is an under-eye hyaluronic acid filler from Galderma, formulated specifically for infraorbital hollowing. It is selected by clinics, dermatologists and aesthetic physicians treating the tear trough, where tissue is thin and a general-purpose filler is unsuitable. The transparent, viscous gel is hyaluronic acid at 20 mg/mL with 0.3% lidocaine hydrochloride, and it is supplied for professional use only.

• Formulated specifically for the delicate under-eye area rather than adapted from a facial filler
• Indicated for the improvement of infraorbital hollowing in patients over the age of 21
• Supplied in a 0,5 mL syringe, which matches the small volumes tear-trough work requires and reduces waste per case
• Transparent, viscous, sterile gel intended for natural-looking correction in thin periorbital skin
• Contains lidocaine hydrochloride 3 mg/mL, relevant in an area patients find highly sensitive
• Hyaluronic acid based, so the implant can be broken down by enzymatic degradation with hyaluronidase where clinically indicated
• Placed supraperiosteally with a 29G x 1/2 inch needle, or with a 25G to 27G blunt-tip cannula

Indications and Professional Use

Main indications

• Improvement of infraorbital hollowing in patients over the age of 21, by supraperiosteal placement

Professional use

Restylane Eyelight Lidocaine is an injectable medical device for administration only by licensed, appropriately trained healthcare practitioners in a controlled clinical setting, and is not for retail sale or self-administration. Periorbital treatment is among the most technically demanding injectable procedures: the skin is thin, the anatomy is unforgiving, and complications are immediately visible, so it should be undertaken only by practitioners with specific training in the region. Injections into the infraorbital hollows are supraperiosteal, using a 29G x 1/2 inch needle or a blunt-tip cannula of 25G to 27G. Patients should be limited to up to 1 ml per side per treatment session. Introduction into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, with rare reports of temporary or permanent vision impairment and blindness, so the product must be injected slowly with the least pressure necessary.

Treatment areas

• Infraorbital hollows, the under-eye area

Patient profile

For patients over the age of 21 assessed as suitable by the treating practitioner. Patient selection is particularly important in this region: skin thickness, fluid retention, existing pigmentation and the presence of fat herniation all affect whether filler is the appropriate answer to under-eye shadowing, and that assessment rests with the practitioner. Because the gel contains lidocaine hydrochloride 3 mg/mL, patients with known hypersensitivity to lidocaine or to other amide-type anaesthetics must not receive it. It is contraindicated in patients with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies, and in patients with a history of allergy to gram-positive bacterial proteins, since the gel contains trace amounts of such material. Use should be deferred at sites where an active inflammatory process or infection is present until that process has been controlled.

How Restylane Eyelight Lidocaine Works

Why Order From Allpara

Allpara offers genuine, verified RESTYLANE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions